iSOFT Debuts Latest Lorenzo version at E-Health Insider Live '09

iSOFTiSOFT is launching its new revitalised brand and showcasing the latest version of its strategic Lorenzo solution at the E-Health Insider Live '09 conference and exhibition in Birmingham next month.

iSOFT, a major sponsor of the conference, is launching its new corporate brand at the event, which has become a key date in the diaries of healthcare IT professionals.

The new brand - 'Humanising Healthcare' - recognizes the company's ambition to make the experience of healthcare more personal and tailored to individuals.

Conference delegates are invited to join iSOFT in celebrating the brand launch at a champagne reception at the iSOFT stand at 4:30pm on Monday, 9 November.

iSOFT product specialists will demonstrate Lorenzo and Viaduct, an integration engine developed by US-based BridgeForward, which iSOFT acquired in August. The latest version of Lorenzo features new patient management and clinical functions developed for the National Programme for IT.

Executive Chairman & CEO Gary Cohen will explain how software innovations are transforming the delivery of healthcare in terms of quality and cost in his keynote address for the Digital Patient Care session of the conference. His presentation, A vision for NHS clinical systems, will begin at 9.30am on Tuesday, 10 November.

"E-Health Insider Live is a major event in iSOFT's UK calendar this year," said Adrian Stevens, Managing Director of iSOFT's UK and Ireland business. "It is the perfect forum for showcasing the latest development in healthcare IT, and we are pleased to be a supporter of this event from the outset. It will be the key date in the healthcare IT calendar for many years."

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.

Today, more than 13,000 provider organisations in more than 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of some 4,700 specialists, including more than 2,700 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

www.isofthealth.com

Most Popular Now

Open Call HORIZON-MISS-2022-CANCER-01-04…

The overall goal of the Mission on Cancer[1] and the Europe's Beating Cancer Plan[2] includes a better quality of life for patients and their families living with, and after, cancer. Project...

Insilico Medicine Raises $60 Million in …

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a $60 million Series D financing from a syndicate of global investors with...

Philips' Future Health Index 2022 Report…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of its Future Health Index (FHI) 2022 report: 'Healthcare hits reset: Priorities shift as...

KTU Researchers Investigate the Links Be…

In recent years Alzheimer's disease has been on the rise throughout the world and is rarely diagnosed at an early stage when it can still be effectively controlled. Using artificial...

Speech Analysis App Predicts Worsening H…

A voice analysis app used by heart failure patients at home recognises fluid in the lungs three weeks before an unplanned hospitalisation or escalation in outpatient drug treatment. The late...

Screening for Diabetic Retinopathy Prove…

Both telemedicine and community screening for diabetic retinopathy (DR) in rural and urban settings are cost-effective in China, and telemedicine screening programs are more cost-effective, according to a study led...

App Detecting Jaundice in Babies a Succe…

A smartphone app that identifies severe jaundice in newborn babies by scanning their eyes could be a life-saver in areas that lack access to expensive screening devices, suggests a study...

Researchers Develop Smartphone-Powered M…

A University of Minnesota Twin Cities research team has developed a new microfluidic chip for diagnosing diseases that uses a minimal number of components and can be powered wirelessly by...

InterSystems Wins Data Driven Product of…

InterSystems, a provider of next-generation solutions for enterprise digital transformation to help customers solve the most critical data challenges, has announced it received the prestigious Data Driven Product of the...

Siemens Healthineers Introduces Symbia P…

Siemens Healthineers introduces Symbia Pro.specta™, a single-photon emission computed tomography/computed tomography (SPECT/CT) system with CE Mark and Food and Drug Administration (FDA) clearance that has advanced SPECT and CT imaging...

Oracle Purchase of Cerner Approved

Oracle Corporation (NYSE: ORCL) announced that all required antitrust approvals have been obtained for its proposed acquisition of Cerner, including European Commission clearance. Cerner is a leading provider of digital...